Company Filing History:
Years Active: 2017
Title: Marwan ElMasri: Innovator in the Field of Lysine Isotopologues
Introduction
Marwan ElMasri is an accomplished inventor based in Groton, Massachusetts, known for his innovative contributions in the field of biochemical compounds. His work primarily revolves around the advancement of amino acids, specifically lysine isotopologues, which holds significant potential in various scientific applications.
Latest Patents
ElMasri holds a notable patent titled "Lysine isotopologues, compositions comprising the same and methods of synthesis." This invention focuses on the development of lysine isotopologues represented by specific formulas, along with the processes involved in their synthesis. The patented chemical compounds include isotopically labeled analogs of naturally occurring lysine, which are synthetically modified to incorporate stable isotopes at designated positions. This results in lysine isotopologues that possess different molecular masses compared to standard lysine.
Career Highlights
ElMasri's career is marked by his role at Cambridge Isotope Laboratories, Inc., where he applies his expertise to further the understanding and development of isotopologue chemistry. His innovative approach has positioned him as a key contributor to the field and has paved the way for advancements in various research areas.
Collaborations
Throughout his professional journey, Marwan ElMasri has collaborated with esteemed colleagues such as Joel Chandler Bradley and William Wakefield Wood. These partnerships have enriched his research experience, fostering an environment of shared knowledge and expertise in the pursuit of scientific discovery.
Conclusion
Marwan ElMasri stands out as a significant figure in the realm of innovations related to biochemical compounds. His patented work with lysine isotopologues is a testament to his ingenuity and commitment to advancing scientific research. Through his collaborations and professional endeavors, he continues to make impactful contributions that benefit the scientific community.